Combining APDM’s precision motion wearables and digital biomarkers with ERT’s eClinical Suite revolutionizes clinical trials ERT, the global leader in…
A new NHS report has detailed how more than 56% of adults are at increased, high or very high risk…
Currently, five PD-1/L1 inhibitors boast FDA approvals to treat certain bladder cancer patients. But only one of them is about…
MultiTEP Platform-Based Epitope Vaccine Targeting the Phosphatase Activating Domain (PAD) of Tau Shows Clear Therapeutic Efficacy in PS19 Mice Capo…
Studies Aim to Confirm Safety and Efficacy of Novel Bio-inspired Clot-dissolving Therapy Thrombolytic Science, LLC (TSI) today announced progress with 10…
A promising vaccine that clears an HIV-like virus from monkeys is closer to human testing after a new, weakened version…
Announces strategic partnership with alytas therapeutics Velabs Therapeutics GmbH (Velabs), a biotech company focused on the rapid screening of functional…
by Anna Smith Cambridge University Hospital NHS Foundation Trust has announced that its inflammatory bowel disease (IBD) research has hit…
Men with breast cancer have significantly fewer treatment options than women with the disease, partly due to exclusion from many…
AstraZeneca today announced that the US Food and Drug Administration (FDA) has granted Fast Track designation for the development of…
